SMS Pharmaceuticals reports consolidated Q1 FY26 at Rs. 20.49 Cr
News

SMS Pharmaceuticals reports consolidated Q1 FY26 at Rs. 20.49 Cr

SMS Pharmaceuticals has reported total income of Rs. 196.64 crores during the period ended June 30, 2025

  • By IPP Bureau | August 11, 2025

SMS Pharmaceuticals Limited has reported consolidated financial results for the period ended June 30, 2025. 

SMS Pharmaceuticals has posted net profit of Rs. 20.49 crores for the period ended June 30, 2025 as against net profit of Rs. 20.31 crores for the period ended March 31, 2025. The company posted net profit of Rs.16.47 crores for the period ended June 30, 2024.

SMS Pharmaceuticals has reported total income of Rs. 196.64 crores during the period ended June 30, 2025 as compared to Rs. 249.61 crores during the period ended March 31, 2025. The company reported total income of Rs.165.81 crores during the period ended June 30, 2024. 

 

Upcoming E-conference

Other Related stories

Startup

Digitization